{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:06:23Z","timestamp":1779149183062,"version":"3.51.4"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"28","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1097\/md.0000000000004174","type":"journal-article","created":{"date-parts":[[2016,7,14]],"date-time":"2016-07-14T14:54:44Z","timestamp":1468508084000},"page":"e4174","source":"Crossref","is-referenced-by-count":15,"title":["Pharmacodynamic correlations using fresh and cryopreserved tissue following use of vaginal rings containing dapivirine and\/or maraviroc in a randomized, placebo controlled trial"],"prefix":"10.1097","volume":"95","author":[{"given":"Charlene S.","family":"Dezzutti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Richardson-Harman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa C.","family":"Rohan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark A.","family":"Marzinke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig J.","family":"Hoesley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lori","family":"Panther","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherri","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy P.","family":"Nuttall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annalene","family":"Nel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatrice A.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-33-20210226","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1086\/462424","article-title":"A human colorectal explant culture to evaluate topical microbicides for the prevention of HIV infection","volume":"192","author":"Abner","year":"2005","journal-title":"J Infect Dis"},{"key":"R2-33-20210226","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/74743","article-title":"Development of an in vitro organ culture model to study transmission of HIV-1 in the female genital tract","volume":"6","author":"Collins","year":"2000","journal-title":"Nat Med"},{"key":"R3-33-20210226","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1128\/AAC.01129-06","article-title":"Preclinical testing of candidate topical microbicides for anti-human immunodeficiency virus type 1 activity and tissue toxicity in a human cervical explant culture","volume":"51","author":"Cummins","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"R4-33-20210226","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1371\/journal.pmed.0050016","article-title":"Antiretroviral pre-exposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT mice","volume":"5","author":"Denton","year":"2008","journal-title":"PLoS Med"},{"key":"R5-33-20210226","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1097\/01.aids.0000232230.96134.80","article-title":"Ex vivo culture of human colorectal tissue for the evaluation of candidate microbicides","volume":"20","author":"Fletcher","year":"2006","journal-title":"AIDS"},{"key":"R6-33-20210226","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1097\/QAD.0b013e32834b3629","article-title":"Colorectal microbicide design: triple combinations of reverse transcriptase inhibitors are optimal against HIV-1 in tissue explants","volume":"25","author":"Herrera","year":"2011","journal-title":"AIDS"},{"key":"R7-33-20210226","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1089\/aid.2005.21.207","article-title":"SPL7013 gel as a topical microbicide for prevention of vaginal transmission of SHIV89.6P in macaques","volume":"21","author":"Jiang","year":"2005","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R8-33-20210226","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1084\/jem.192.10.1491","article-title":"Candidate microbicides block HIV-1 infection of human immature Langerhans cells within epithelial tissue explants","volume":"192","author":"Kawamura","year":"2000","journal-title":"J Exp Med"},{"key":"R9-33-20210226","doi-asserted-by":"crossref","first-page":"10358","DOI":"10.1128\/JVI.01073-09","article-title":"Complete protection from repeated vaginal simian-human immunodeficiency virus exposures in macaques by a topical gel containing tenofovir alone or with emtricitabine","volume":"83","author":"Parikh","year":"2009","journal-title":"J Virol"},{"key":"R10-33-20210226","doi-asserted-by":"crossref","first-page":"e9310","DOI":"10.1371\/journal.pone.0009310","article-title":"In vitro and ex vivo testing of tenofovir shows it is effective as an HIV-1 microbicide","volume":"5","author":"Rohan","year":"2010","journal-title":"PLoS One"},{"key":"R11-33-20210226","doi-asserted-by":"crossref","first-page":"150ra123","DOI":"10.1126\/scitranslmed.3003936","article-title":"An intravaginal ring that releases the NNRTI MIV-150 reduces SHIV transmission in macaques","volume":"4","author":"Singer","year":"2012","journal-title":"Sci Transl Med"},{"key":"R12-33-20210226","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1089\/088922203322230897","article-title":"Cyanovirin-N gel as a topical microbicide prevents rectal transmission of SHIV89.6P in macaques","volume":"19","author":"Tsai","year":"2003","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R13-33-20210226","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/00002030-200303280-00002","article-title":"Blocking of cell-free and cell-associated HIV-1 transmission through human cervix organ culture with UC781","volume":"17","author":"Zussman","year":"2003","journal-title":"AIDS"},{"key":"R14-33-20210226","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1086\/655661","article-title":"Protection of rhesus macaques from vaginal infection by vaginally delivered maraviroc, an inhibitor of HIV-1 entry via the CCR5 co-receptor","volume":"202","author":"Veazey","year":"2010","journal-title":"J Infect Dis"},{"key":"R15-33-20210226","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1128\/JVI.05842-11","article-title":"Durable protection from vaginal simian-human immunodeficiency virus infection in macaques by tenofovir gel and its relationship to drug levels in tissue","volume":"86","author":"Dobard","year":"2012","journal-title":"J Virol"},{"key":"R16-33-20210226","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.antiviral.2012.08.004","article-title":"Safety and efficacy of tenofovir\/IQP-0528 combination gels - a dual compartment microbicide for HIV-1 prevention","volume":"96","author":"Dezzutti","year":"2012","journal-title":"Antiviral Res"},{"key":"R17-33-20210226","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1126\/science.1193748","article-title":"Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women","volume":"329","author":"Abdool Karim","year":"2010","journal-title":"Science"},{"key":"R19-33-20210226","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/QAD.0b013e32834541d9","article-title":"Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in women","volume":"25","author":"Abdool Karim","year":"2011","journal-title":"AIDS"},{"key":"R20-33-20210226","doi-asserted-by":"crossref","first-page":"e1474","DOI":"10.1371\/journal.pone.0001474","article-title":"SAVVY vaginal gel (C31G) for prevention of HIV infection: a randomized controlled trial in Nigeria","volume":"3","author":"Feldblum","year":"2008","journal-title":"PLoS One"},{"key":"R21-33-20210226","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1016\/S0140-6736(08)61842-5","article-title":"Efficacy of carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial","volume":"372","author":"Skoler-Karpoff","year":"2008","journal-title":"Lancet"},{"key":"R22-33-20210226","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1056\/NEJMoa0707957","article-title":"Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission","volume":"359","author":"Van Damme","year":"2008","journal-title":"N Engl J Med"},{"key":"R23-33-20210226","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(02)11079-8","article-title":"Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial","volume":"360","author":"Van Damme","year":"2002","journal-title":"Lancet"},{"key":"R24-33-20210226","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1056\/NEJMoa1402269","article-title":"Tenofovir-based preexposure prophylaxis for HIV infection among African women","volume":"372","author":"Marrazzo","year":"2015","journal-title":"N Engl J Med"},{"key":"R25-33-20210226","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1089\/aid.2012.0262","article-title":"RMP-02\/MTN-006: A phase 1 rectal safety, acceptability, pharmacokinetic, and pharmacodynamic study of tenofovir 1% gel compared with oral tenofovir disoproxil fumarate","volume":"28","author":"Anton","year":"2012","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R26-33-20210226","doi-asserted-by":"crossref","first-page":"e23243","DOI":"10.1371\/journal.pone.0023243","article-title":"First phase 1 double-blind, placebo-controlled, randomized rectal microbicide trial using UC781 Gel with a novel index of ex vivo efficacy","volume":"6","author":"Anton","year":"2011","journal-title":"PLoS One"},{"key":"R27-33-20210226","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/QAI.0b013e318291f331","article-title":"HIV-1 infection of female genital tract tissue for use in prevention studies","volume":"5","author":"Dezzutti","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R28-33-20210226","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/QAI.0000000000000897","article-title":"A phase 1 trial to assess the safety, acceptability, pharmacokinetics, and pharmacodynamics of a novel dapivirine vaginal film","volume":"71","author":"Bunge","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R29-33-20210226","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/QAI.0000000000000702","article-title":"Phase 1 safety, pharmacokinetics, and pharmacodynamics of dapivirine and maraviroc vaginal rings: a double-blind randomized trial","volume":"70","author":"Chen","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R30-33-20210226","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1089\/aid.2012.0073","article-title":"Dose-response relationship between tissue concentrations of UC781 and explant infectibility with HIV type 1 in the RMP-01 rectal safety study","volume":"28","author":"Richardson-Harman","year":"2012","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R31-33-20210226","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1093\/cid\/ciu250","article-title":"Pharmacology lessons from chemoprophylaxis studies","volume":"59","author":"Boffito","year":"2014","journal-title":"Clin Infect Dis"},{"key":"R32-33-20210226","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1124\/dmd.114.060194","article-title":"CYP3A5 genotype impacts maraviroc concentrations in healthy volunteers","volume":"42","author":"Lu","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"R33-33-20210226","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.cca.2014.02.008","article-title":"Development and bioanalytical validation of a liquid chromatographic-tandem mass spectrometric (LC-MS\/MS) method for the quantification of the CCR5 antagonist maraviroc in human plasma","volume":"431","author":"Emory","year":"2014","journal-title":"Clin Chim Acta"},{"key":"R34-33-20210226","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jpba.2014.06.018","article-title":"Dual quantification of dapivirine and maraviroc in cervicovaginal secretions from ophthalmic tear strips and polyester-based swabs via liquid chromatographic-tandem mass spectrometric (LC-MS\/MS) analysis","volume":"98C","author":"Parsons","year":"2014","journal-title":"J Pharm Biomed Anal"},{"key":"R35-33-20210226","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.4155\/bio.13.256","article-title":"The development and validation of an UHPLC-MS\/MS method for the rapid quantification of the antiretroviral agent dapivirine in human plasma","volume":"5","author":"Seserko","year":"2013","journal-title":"Bioanalysis"},{"key":"R37-33-20210226","doi-asserted-by":"crossref","first-page":"e111507","DOI":"10.1371\/journal.pone.0111507","article-title":"Correlation between compartmental tenofovir concentrations and an ex vivo rectal biopsy model of tissue infectibility in the RMP-02\/MTN-006 phase 1 study","volume":"9","author":"Richardson-Harman","year":"2014","journal-title":"PLoS One"},{"key":"R38-33-20210226","first-page":"355","article-title":"Pharmacokinetics and safety assessment of anti-HIV dapivirine vaginal microbicide rings with multiple dosing","volume":"5","author":"Nel","year":"2014","journal-title":"J AIDS Clin Res"},{"key":"R39-33-20210226","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/jcph.248","article-title":"Expression of six drug transporters in vaginal, cervical, and colorectal tissues: Implications for drug disposition in HIV prevention","volume":"54","author":"Nicol","year":"2014","journal-title":"J Clin Pharmacol"},{"key":"R40-33-20210226","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1089\/aid.2013.0281","article-title":"Expression and localization of p-glycoprotein, multidrug resistance protein 4, and breast cancer resistance protein in the female lower genital tract of human and pigtailed macaque","volume":"30","author":"Zhou","year":"2014","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R41-33-20210226","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1177\/135965350901400514","article-title":"Maraviroc: pharmacokinetics and drug interactions","volume":"14","author":"Abel","year":"2009","journal-title":"Antivir Ther"},{"key":"R42-33-20210226","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/164666a0","article-title":"Revival of spermatozoa after vitrification and dehydration at low temperatures","volume":"164","author":"Polge","year":"1949","journal-title":"Nature"},{"key":"R43-33-20210226","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1089\/aid.2006.22.419","article-title":"Use of frozen-thawed cervical tissues in the organ culture system to measure anti-HIV activities of candidate microbicides","volume":"22","author":"Gupta","year":"2006","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R44-33-20210226","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1089\/aid.2012.0062","article-title":"Nonreproducibility of \u201csnap-frozen\u201d rectal biopsies for later use in ex vivo explant infectibility studies","volume":"28","author":"McGowan","year":"2012","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R45-33-20210226","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0305-4179(99)00169-2","article-title":"Effect of storage and preservation methods on viability in transplantable human skin allografts","volume":"26","author":"Bravo","year":"2000","journal-title":"Burns"},{"key":"R46-33-20210226","doi-asserted-by":"crossref","first-page":"8426","DOI":"10.1016\/j.biomaterials.2011.07.008","article-title":"Cryopreservation of tissue-engineered epithelial sheets in trehalose","volume":"32","author":"Chen","year":"2011","journal-title":"Biomaterials"},{"key":"R47-33-20210226","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11552-007-9062-2","article-title":"Cryopreservation of composite tissue transplants","volume":"3","author":"Rinker","year":"2008","journal-title":"Hand"},{"key":"R48-33-20210226","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/pro.3","article-title":"Effect of trehalose on protein structure","volume":"18","author":"Jain","year":"2009","journal-title":"Protein Sci"},{"key":"R49-33-20210226","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/j.1537-2995.2007.01212.x","article-title":"Cryopreservation of living cells: principles and practice","volume":"47","author":"Meryman","year":"2007","journal-title":"Transfusion"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000004174","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T06:53:36Z","timestamp":1718693616000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201607120-00033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":47,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000004174","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]}}}